ClinVar Genomic variation as it relates to human health
NM_001927.4(DES):c.1353C>G (p.Ile451Met)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_001927.4(DES):c.1353C>G (p.Ile451Met)
Variation ID: 16824 Accession: VCV000016824.20
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 2q35 2: 219425727 (GRCh38) [ NCBI UCSC ] 2: 220290449 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Oct 19, 2013 May 1, 2024 Jan 28, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_001927.4:c.1353C>G MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_001918.3:p.Ile451Met missense NC_000002.12:g.219425727C>G NC_000002.11:g.220290449C>G NG_008043.1:g.12351C>G LRG_380:g.12351C>G LRG_380t1:c.1353C>G LRG_380p1:p.Ile451Met P17661:p.Ile451Met - Protein change
- I451M
- Other names
-
p.I451M:ATC>ATG
- Canonical SPDI
- NC_000002.12:219425726:C:G
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
-
0.00220 (T)
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
Trans-Omics for Precision Medicine (TOPMed) 0.00007
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
DES | - | - |
GRCh38 GRCh37 |
1066 | 1112 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Uncertain significance (2) |
criteria provided, single submitter
|
Nov 28, 2017 | RCV000018318.42 | |
Uncertain significance (5) |
criteria provided, multiple submitters, no conflicts
|
Oct 5, 2023 | RCV000056787.20 | |
Uncertain significance (2) |
criteria provided, multiple submitters, no conflicts
|
Jan 28, 2024 | RCV000698481.15 | |
Uncertain significance (1) |
criteria provided, single submitter
|
May 2, 2022 | RCV002265561.8 | |
Uncertain significance (1) |
criteria provided, single submitter
|
Dec 30, 2020 | RCV004018640.1 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Uncertain significance
(Jan 28, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Desmin-related myofibrillar myopathy
Desmin-related myofibrillar myopathy
Explanation for multiple conditions: Uncertain.
The variant was classified for several related diseases, possibly a spectrum of disease; the variant may be associated with one or more the diseases.
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV000827147.4
First in ClinVar: Oct 10, 2018 Last updated: Feb 28, 2024 |
Comment:
This sequence change replaces isoleucine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 451 of the DES protein (p.Ile451Met). … (more)
This sequence change replaces isoleucine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 451 of the DES protein (p.Ile451Met). This variant is present in population databases (rs121913002, gnomAD 0.02%). This missense change has been observed in individual(s) with DES-related conditions (PMID: 10430757, 10717012, 11728149, 30403391, 30847666). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 16824). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on DES protein function. Experimental studies have shown that this missense change affects DES function (PMID: 17105773, 17221859, 18539904, 28470624). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. (less)
|
|
Uncertain significance
(Aug 12, 2016)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Eurofins Ntd Llc (ga)
Accession: SCV000343109.4
First in ClinVar: Dec 06, 2016 Last updated: Dec 15, 2018 |
Number of individuals with the variant: 1
Zygosity: Single Heterozygote
Sex: mixed
|
|
Uncertain significance
(Jul 10, 2018)
|
criteria provided, single submitter
Method: clinical testing
|
Desmin-related myofibrillar myopathy
Affected status: unknown
Allele origin:
germline
|
Illumina Laboratory Services, Illumina
Accession: SCV001300905.1
First in ClinVar: May 31, 2020 Last updated: May 31, 2020 |
Comment:
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, … (more)
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. (less)
|
|
Uncertain significance
(Nov 28, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
Dilated cardiomyopathy 1I
Affected status: unknown
Allele origin:
germline
|
Illumina Laboratory Services, Illumina
Accession: SCV001300906.1
First in ClinVar: May 31, 2020 Last updated: May 31, 2020 |
Comment:
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, … (more)
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. (less)
|
|
Uncertain significance
(May 02, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
not specified
Affected status: unknown
Allele origin:
germline
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Accession: SCV002548221.1
First in ClinVar: Jul 18, 2022 Last updated: Jul 18, 2022 |
Comment:
Variant summary: DES c.1353C>G (p.Ile451Met) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging … (more)
Variant summary: DES c.1353C>G (p.Ile451Met) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 6.4e-05 in 233386 control chromosomes. The observed variant frequency is approximately 2.1 fold of the estimated maximal expected allele frequency for a pathogenic variant in DES causing Dilated Cardiomyopathy phenotype (3.1e-05), strongly suggesting that the variant is benign. c.1353C>G has been reported in the literature in individuals affected with Dilated Cardiomyopathy (DCM) (example, Li_1999, Miyamoto_2001, van Lint_2019), in unaffected family members (example, Li_1999, Dalakas_2003), and individuals with skeletal myopathy without DCM (example, Dalakas_2000, Dalakas_2003). These data indicate that the variant may be associated with disease. At least two publications report experimental evidence evaluating an impact on protein function (example, Dalakas_2003, Mavrodis_2008). One study reported that this variant was functional and normally interacted with other intermediate filaments (Dalakas_2003) while another reported that mutant desmin loses its Z-disc localization but it can still associate with the intercalated discs, which, however, have an altered architecture, resembling other examples of dilated cardiomyopathy (Mavrodis_2008). These results however, do not allow convincing conclusions about the variant effect. Six clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation (VUS, n=5; Benign, n=1). Based on the evidence outlined above, the variant was classified as uncertain significance. (less)
|
|
Uncertain significance
(Oct 05, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000235800.13
First in ClinVar: Jul 05, 2015 Last updated: Nov 25, 2023 |
Comment:
Reported in association with DCM and HCM, and was shown to segregate with disease in one affected relative from a single family; however, only the … (more)
Reported in association with DCM and HCM, and was shown to segregate with disease in one affected relative from a single family; however, only the DES gene was analyzed in this family (Li et al., 1999; van Lint et al., 2019; Oktay et al., 2023); Identified in three affected relatives from one family with skeletal myopathy; however, only the DES gene was analyzed in these individuals (Dalakas et al., 2003).; Functional studies have been inconsistent in demonstrating a damaging effect (Lapouge et al., 2006; Mavroidis et al., 2008; Sharma et al., 2017; Dalakas et al., 2003; Bar et al., 2007; Chourbagi et al., 2011).; In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 36935760, 16761416, 11052860, 21262226, 17221859, 28470624, 18539904, 16979163, 30403391, 26807690, 30847666, 11728149, 37466024, 12609507, 17105773, 10430757) (less)
|
|
Uncertain significance
(Dec 30, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
Cardiovascular phenotype
Affected status: unknown
Allele origin:
germline
|
Ambry Genetics
Accession: SCV004856351.1
First in ClinVar: May 01, 2024 Last updated: May 01, 2024 |
Comment:
The c.1353C>G (p.I451M) alteration is located in exon 8 (coding exon 8) of the DES gene. This alteration results from a C to G substitution … (more)
The c.1353C>G (p.I451M) alteration is located in exon 8 (coding exon 8) of the DES gene. This alteration results from a C to G substitution at nucleotide position 1353, causing the isoleucine (I) at amino acid position 451 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. (less)
|
|
Pathogenic
(Aug 03, 1999)
|
no assertion criteria provided
Method: literature only
|
CARDIOMYOPATHY, DILATED, 1I
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000038597.9
First in ClinVar: Apr 04, 2013 Last updated: Aug 02, 2020 |
Comment on evidence:
In a family with autosomal dominant pure dilated cardiomyopathy (CMD1I; 604765), Li et al. (1999) identified a heterozygous C-to-G transversion at nucleotide 1353 of the … (more)
In a family with autosomal dominant pure dilated cardiomyopathy (CMD1I; 604765), Li et al. (1999) identified a heterozygous C-to-G transversion at nucleotide 1353 of the DES gene, resulting in an ile451-to-met substitution. This mutation was not present in 920 control chromosomes. The residue involved is located in the carboxy tail domain of the protein, suggesting an important functional role for this region in cardiac myocytes. Miyamoto et al. (2001) screened exon 8 of the DES gene in a cohort of 265 Japanese probands with dilated cardiomyopathy and identified 3 unrelated men who were heterozygous for the I451M substitution. None of the 3 patients showed any clinical evidence of skeletal muscle involvement on physical examination, and none had abnormal levels of creatine kinase or a myopathic pattern on electromyelogram. All 3 cases were sporadic; in the 1 family in which parental DNA was available, the mutation was shown to have arisen de novo. Haplotype analysis indicated that 2 of the men might have been ancestrally related. (less)
|
|
Likely pathogenic
(-)
|
no assertion criteria provided
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Clinical Genetics, Academic Medical Center
Additional submitter:
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Study: VKGL Data-share Consensus
Accession: SCV001925897.1 First in ClinVar: Sep 24, 2021 Last updated: Sep 24, 2021 |
|
|
Likely pathogenic
(-)
|
no assertion criteria provided
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Study: VKGL Data-share Consensus
Accession: SCV001963222.1 First in ClinVar: Oct 08, 2021 Last updated: Oct 08, 2021 |
|
|
not provided
(-)
|
no classification provided
Method: not provided
|
not provided
Affected status: not provided
Allele origin:
not provided
|
Epithelial Biology; Institute of Medical Biology, Singapore
Accession: SCV000087900.1
First in ClinVar: Oct 19, 2013 Last updated: Oct 19, 2013 |
|
|
click to load more click to collapse |
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Large next-generation sequencing gene panels in genetic heart disease: yield of pathogenic variants and variants of unknown significance. | van Lint FHM | Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation | 2019 | PMID: 30847666 |
Sudden cardiac arrest in patients without overt heart disease: a limited value of next generation sequencing. | Stępień-Wojno M | Polish archives of internal medicine | 2018 | PMID: 30403391 |
αB-crystallin is a sensor for assembly intermediates and for the subunit topology of desmin intermediate filaments. | Sharma S | Cell stress & chaperones | 2017 | PMID: 28470624 |
Desmin mutations in the terminal consensus motif prevent synemin-desmin heteropolymer filament assembly. | Chourbagi O | Experimental cell research | 2011 | PMID: 21262226 |
A missense mutation in desmin tail domain linked to human dilated cardiomyopathy promotes cleavage of the head domain and abolishes its Z-disc localization. | Mavroidis M | FASEB journal : official publication of the Federation of American Societies for Experimental Biology | 2008 | PMID: 18539904 |
Conspicuous involvement of desmin tail mutations in diverse cardiac and skeletal myopathies. | Bär H | Human mutation | 2007 | PMID: 17221859 |
New insights into the molecular basis of desmoplakin- and desmin-related cardiomyopathies. | Lapouge K | Journal of cell science | 2006 | PMID: 17105773 |
Progressive skeletal myopathy, a phenotypic variant of desmin myopathy associated with desmin mutations. | Dalakas MC | Neuromuscular disorders : NMD | 2003 | PMID: 12609507 |
Frequency and clinical characteristics of dilated cardiomyopathy caused by desmin gene mutation in a Japanese population. | Miyamoto Y | European heart journal | 2001 | PMID: 11728149 |
Abnormal desmin protein in myofibrillar myopathies caused by desmin gene mutations. | Li M | Annals of neurology | 2001 | PMID: 11310634 |
Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. | Dalakas MC | The New England journal of medicine | 2000 | PMID: 10717012 |
Desmin mutation responsible for idiopathic dilated cardiomyopathy. | Li D | Circulation | 1999 | PMID: 10430757 |
http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=DES | - | - | - | - |
click to load more click to collapse |
Text-mined citations for rs121913002 ...
HelpRecord last updated Nov 25, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.